Due to the COVID-19 situation, governments across the world initiated lockdown and quarantines. The lockdowns have a severe impact on pharmaceutical manufacturing across the globe. Some of that include:
Shortage of raw materials
Severe financial damage
All those obstacles lead to a unique manufacturing environment, which may lead to quality deficiencies.
During their talk, Hitendrakumar Shah, the CEO of NADH+ GXP Compliance Services, shared with Yan Kugel his suggestions on how to avoid quality issues during manufacturing, throughout that particular time.
Information on good manufacturing practices (GMP) in the life science industry is scattered, vague and poorly organized. We have chosen to solve this problem by organizing the best possible GMP webinars and courses to ensure we deliver all the information you need in a concise, engaging and clear format. All events are free and open to anyone in the industry.
Mr. Hitendrakumar Shah is the CEO of NADH+ GXP Compliance Services. He has over 21 years of experience in Quality Assurance, Quality Control, quality engineering, pharmaceutical regulations, and regulatory audit compliance.